首页 › 基金 › RA CAPITAL MANAGEMENT, L.P. › AKTS

RA CAPITAL MANAGEMENT, L.P. 对 AKTS 的持仓历史

AKTIS ONCOLOGY INC · 医疗保健

RA CAPITAL MANAGEMENT, L.P. 在 Q2 2026 的 13F 申报中披露持有 AKTS(AKTIS ONCOLOGY INC)1,314,405 股,市值约 US$42.4M,约占其申报组合的 0.37%,在其申报持仓中市值排名第 44 位。 RA CAPITAL MANAGEMENT, L.P. 最近 2 个申报季度中有 2 个季度披露了 AKTS 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q2 2026)1.31M 股
申报持仓市值$42.36M
组合权重0.37%
首次申报Q1 2026
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

RA CAPITAL MANAGEMENT, L.P. 对 AKTS 的持仓演变

RA CAPITAL MANAGEMENT, L.P. 于 Q1 2026 首次披露 AKTS 持仓:1,503,084 股(约 US$26.9M)。 该持仓在 Q2 2026 达到峰值 1,314,405 股,市值约 US$42.4M。 在 2 次申报中,RA CAPITAL MANAGEMENT, L.P. 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 1,314,405 股、市值约 US$42.4M,环比减持 -188,679 股。。

逐季持仓明细

季度股数金额变化
Q1 2026 1.50M $26.89M 新进
Q2 2026 1.31M $42.36M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 AKTS 与 13F 数据

AKTS(AKTIS ONCOLOGY INC)属于医疗保健行业。我们追踪的基金中还有 121 只申报持有 AKTS,申报仓位最大的包括:MPM BioImpact LLC (US$155.9M), EcoR1 Capital, LLC (US$155.5M), Blue Owl Capital Holdings LP (US$99.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 AKTS 的基金

查看 AKTS 的全部基金持有人 →

常见问题

How long has RA CAPITAL MANAGEMENT, L.P. held AKTS?

RA CAPITAL MANAGEMENT, L.P. has disclosed AKTS holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is RA CAPITAL MANAGEMENT, L.P.'s current position in AKTS?

As of Q2 2026, RA CAPITAL MANAGEMENT, L.P. holds 1.31M shares of AKTS (AKTIS ONCOLOGY INC), valued at $42.36M, representing 0.37% of its reported portfolio and ranking #44.

Has RA CAPITAL MANAGEMENT, L.P. been buying or selling AKTS?

In the latest 13F filing (Q2 2026), RA CAPITAL MANAGEMENT, L.P. reduced its position in AKTS. The position peaked in Q2 2026 at 1.31M shares.

Which other funds hold AKTS?

Other major institutional holders of AKTS include MPM BioImpact LLC, EcoR1 Capital, LLC, Blue Owl Capital Holdings LP, among 121 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.